🔴 Jasper Therapeutics is trading 8.63% down in pre-market as renewed U.S.-Iran clashes intensify global risk-off sentiment

Jasper Therapeutics is trading 8.63% down at $0.65 in pre-market after renewed U.S.-Iran clashes intensified global risk-off sentiment.

• Reuters reported oil prices rose amid renewed supply-disruption fears, with Brent reaching $91.94 per barrel on September 1.
• No new company-specific announcement or filing was identified for September 1, 2026.
• Weaker U.S. futures, including Nasdaq Composite futures down 0.95%, reinforced broader pressure as geopolitical tensions and potentially higher rates weighed on risk appetite.